These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29610160)

  • 1. The Use of Pyridostigmine in a Child With Chronic Intestinal Pseudo-Obstruction.
    Choudhury A; Rahyead A; Kammermeier J; Mutalib M
    Pediatrics; 2018 Apr; 141(Suppl 5):S404-S407. PubMed ID: 29610160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series.
    Manini ML; Camilleri M; Grothe R; Di Lorenzo C
    Paediatr Drugs; 2018 Apr; 20(2):173-180. PubMed ID: 29243034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review.
    Wilkie BD; Noori J; Johnston M; Woods R; Keck JO; Behrenbruch C
    ANZ J Surg; 2023 Sep; 93(9):2086-2091. PubMed ID: 37132128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic intestinal pseudo-obstruction.
    Sadjadpour K
    Mayo Clin Proc; 1989 Jun; 64(6):728. PubMed ID: 2747296
    [No Abstract]   [Full Text] [Related]  

  • 5. Prokinetics in the treatment of acute intestinal pseudo-obstruction.
    De Giorgio R; Stanghellini V; Barbara G; Guerrini S; Lioce A; Vasina V; Tonini M; Cola B; Corinaldesi R; De Ponti F
    IDrugs; 2004 Feb; 7(2):160-5. PubMed ID: 15057661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine.
    O'Dea CJ; Brookes JH; Wattchow DA
    Colorectal Dis; 2010 Jun; 12(6):540-8. PubMed ID: 19508545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal pseudo-obstruction in myotonic dystrophy.
    Brunner HG; Hamel BC; Rieu P; Höweler CJ; Peters FT
    J Med Genet; 1992 Nov; 29(11):791-3. PubMed ID: 1453429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intestinal pseudo-obstruction].
    Heilmann G; Erckenbrecht JF
    Ther Umsch; 1994 Mar; 51(3):208-15. PubMed ID: 8160167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Pyridostigmine-responsive Visceral Myopathy With ACTG2 Mutations: A Case Series.
    Lee H; Park S; Oh JT; Kim HM; Kim S; Lee JS
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):e16-e17. PubMed ID: 30334933
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisapride in the treatment of chronic intestinal pseudo-obstruction.
    Reyntjens A; Verlinden M; Schuermans V
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():79-84; discussion 92-3. PubMed ID: 2192509
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review.
    Di Nardo G; Viscogliosi F; Esposito F; Stanghellini V; Villa MP; Parisi P; Morlando A; Caló G; De Giorgio R
    J Neurogastroenterol Motil; 2019 Oct; 25(4):508-514. PubMed ID: 31587541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls.
    Menys A; Butt S; Emmanuel A; Plumb AA; Fikree A; Knowles C; Atkinson D; Zarate N; Halligan S; Taylor SA
    Neurogastroenterol Motil; 2016 Mar; 28(3):376-83. PubMed ID: 26661570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prucalopride in treatment of chronic constipation and recurrent functional obstruction in a patient with steinert myotonic dystrophy.
    Giglio MC; Luglio G; Tarquini R; Cerbone D; Bucci P; Bucci L
    J Clin Gastroenterol; 2015 Jan; 49(1):85-6. PubMed ID: 24804990
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.
    Robinson-Papp J; Nmashie A; Pedowitz E; George MC; Sharma S; Murray J; Benn EKT; Lawrence SA; Machac J; Heiba S; Kim-Schulze S; Navis A; Roland BC; Morgello S
    J Neurovirol; 2019 Aug; 25(4):551-559. PubMed ID: 31098925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical recovery of chronic intestinal pseudo-obstruction with cisapride in a complex pediatric patient.
    Cameron JC; Vaillancourt R; Major-Cook N; Boland M; Zucker M; Lariviere D
    Am J Hosp Palliat Care; 2013 Jun; 30(4):403-5. PubMed ID: 22964344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antroduodenal motility in children with chronic intestinal pseudo-obstruction.
    Hyman PE; McDiarmid SV; Napolitano J; Abrams CE; Tomomasa T
    J Pediatr; 1988 Jun; 112(6):899-905. PubMed ID: 3373394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic manometry in children with chronic intestinal pseudo-obstruction.
    Di Lorenzo C; Flores AF; Reddy SN; Snape WJ; Bazzocchi G; Hyman PE
    Gut; 1993 Jun; 34(6):803-7. PubMed ID: 8314513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal pseudoobstruction as a feature of myotonic muscular dystrophy.
    Füger K; Barnert J; Höpfner W; Wienbeck M
    Z Gastroenterol; 1995 Sep; 33(9):534-8. PubMed ID: 8525657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute on chronic intestinal pseudoobstruction responds to neostigmine.
    Borgaonkar MR; Lumb B
    Dig Dis Sci; 2000 Aug; 45(8):1644-7. PubMed ID: 11007118
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudo-obstruction in children.
    Peck SN; Altschuler SM
    Gastroenterol Nurs; 1992 Feb; 14(4):184-8. PubMed ID: 1377952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.